Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FNTA | P49354 | 4/20 | 0.39 |
| ▸ | FNTB | P49356 | 4/20 | 0.39 |
| ▸ | PGGT1B | P53609 | 4/20 | 0.39 |
| ▸ | EBP | Q15125 | 2/20 | 0.39 |
| ▸ | SIGMAR1 | Q99720 | 2/20 | 0.39 |
| ▸ | CTSS | P25774 | 2/20 | 0.37 |
| ▸ | CTSK | P43235 | 2/20 | 0.37 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.36 |
| ▸ | CTSL | P07711 | 1/20 | 0.36 |
| ▸ | ANPEP | P15144 | 1/20 | 0.35 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.34 |
| ▸ | CTSB | P07858 | 1/20 | 0.34 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7316235 | 1.00 | FNTA (0.39) | FNTAFNTBPGGT1BEBPSIGMAR1 | |
| SCHEMBL7312048 | 1.00 | FNTA (0.39) | FNTAFNTBPGGT1BEBPSIGMAR1 | |
| SCHEMBL7314588 | 0.94 | CACNA1B (0.38) | FNTAFNTBPGGT1BEBPSIGMAR1 | |
| SCHEMBL7306029 | 0.93 | FNTA (0.36) | FNTAFNTBPGGT1BEBPSIGMAR1 | |
| SCHEMBL7313466 | 0.93 | FNTA (0.39) | FNTAFNTBPGGT1BEBPSIGMAR1 | |
| SCHEMBL7316498 | 0.92 | FNTA (0.39) | FNTAFNTBPGGT1BCTSSCTSK | |
| SCHEMBL7307016 | 0.92 | EPHX2 (0.36) | FNTAFNTBPGGT1BEBPSIGMAR1 | |
| SCHEMBL7316023 | 0.89 | FNTA (0.43) | FNTAFNTBPGGT1BEBPSIGMAR1 | |
| SCHEMBL7307986 | 0.88 | FNTA (0.42) | FNTAFNTBPGGT1BEBPSIGMAR1 | |
| SCHEMBL7304422 | 0.87 | CTSL (0.50) | EBPSIGMAR1CTSSCTSKCTSL |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-10095758-A | — | — | None | — | — | JP | disclosed |
| JP-H1095758-A | TREATING AGENT FOR DISEASE OF CENTRAL NERVOUS SYSTEM | LILLY IND LTD | 1998-04-14 | — | — | JP | disclosed |
| EP-0805147-A1 | Novel N-substituted alpha aminoacid amides as calcium channel modulators | LILLY INDUSTRIES LIMITED (GB) | 1997-11-05 | — | — | EP | disclosed |